NCT00937937 2026-05-29Dinaciclib in Treating Patients With Stage IV MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting72 enrolled 14 charts
NCT01434316 2026-04-13Veliparib and Dinaciclib in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Active not recruiting121 enrolled